Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

1 - 20  of 48562 results

Filter or search again

Sort by:  Latest first

  • Blood pressure devices giving inaccurate readings, study finds

    31 OCT 2014

    Blood pressure devices designed for use at home can give inaccurate readings for as many as 15% of users.

  • Experimental drug holds promise for Ewing sarcoma patients

    31 OCT 2014

    Strategy for interfering with DNA repair offers potential treatment for Ewing sarcoma.

  • Which career pathway: community or hospital pharmacy?

    31 OCT 2014

    Are you trying to decide between the hospital and community sectors? Gareth Malson explains what you can expect from both, including responsibilities, salaries and career progression.

  • Dexamethasone safety update

    31 OCT 2014

    The Medicines and Healthcare products Regulatory Agency has issued a drug safety update for dexamethasone. From October 2014, the Dexamethasone 4mg/ml injection (Organon Laboratories Limited) will be replaced with a new formulation called Dexamethasone 3.8 mg/ml solution for injection (Aspen Pharma Trading Limited). The new product has different storage requirements, packaging and presentation.

  • WHO consultation on clinical trials

    31 OCT 2014

    The World Health Organization (WHO) has launched a consultation on public access to clinical trial results. Further information can be found on the WHO website. The deadline for sending comments is 15 November 2014.

  • Incluse Ellipta launch

    31 OCT 2014

    GlaxoSmithKline has launched Incluse Ellipta (umeclidinium) as a maintenance treatment option for chronic obstruvctive pulmonary disease. List price, 30 x 55mcg inhalation, £27.50.

  • Ebola poster issued

    31 OCT 2014

    NHS England and the Department for Health have issued a poster about Ebola to be displayed in pharmacies and another for pharmacy staff. Public Health Wales has issued a bilingual version. Posters can be downloaded for free from the Pharmaceutical Services Negotiating Committee website.

  • Headlice product

    31 OCT 2014

    A new headlice treatment device has been launched by Allergy Kids called Nitview Ledcomb. It consists of a comb with micro-channelled teeth and a UV light that identifies the presence of lice or eggs. Recommended retail price, £25.

  • Propylthiouracil reimbursement

    31 OCT 2014

    The Department of Health and National Assembly for Wales have made a new determination that the reimbursement price in the month of October 2014 for propylthiouracil 50mg tablets is £60.00 instead of £49.01 as stated in the Drug Tariff.

  • Avastin wound healing warning

    31 OCT 2014

    The summary of product characteristics for Avastin (bevacizumab; Roche) has been updated to warn that serious wound healing complications, including anastomotic complications, with a fatal outcome have been reported.

  • Thursday 27 November: Yorkshire

    31 OCT 2014

    Local practice forum event, ‘Research Ready: Recognition, Support and Action’. University of Bradford, Richmond building, Richmond Road, Bradford, Yorkshire BD7 1DP. Event 7.30pm, buffet 7pm. Book via the RPS website.

  • Disappointing results for fish oil in atrial fibrillation trial

    31 OCT 2014

    Study suggests high doses of fish oil supplements do not reduce atrial fibrillation, a common type of irregular heartbeat.

  • New technique produces chirally pure molecules

    30 OCT 2014

    Researchers based in the US look at a new way to create chirally pure molecules to help discover drugs.

  • E-cigarettes: proceed with caution

    30 OCT 2014

    I note that your online poll suggests support for the sale of e-cigarettes in pharmacies (2014;293:412). It is not clear who you polled but that is beside the point.

  • Timothy House dies

    30 OCT 2014

    On 21 October, Timothy House MRPharmS, aged 63, of 1 Chaplains Close, Haverhill, Suffolk CB9 0DT. Mr House registered in 1973.

  • Valcyte shelf life

    30 OCT 2014

    The shelf life of Valcyte (valganciclovir hydrochloride; Roche) powder for oral suspension 50mg/ml has been extended from two to three years.

  • Polymixin antibiotics

    30 OCT 2014

    Following a review, the European Medicines Agency has recommended that the product information of polymixin-based antibiotics (colistin and colistimethate sodium) should be updated to state that the dose should always be expressed in international units, that intravenous treatment ...

  • Questions should be asked about how health commissioners recirculate funding to GPs

    30 OCT 2014

    Income from local enhanced services that were historically delivered by GPs could and should be open to competition, not just recycled to general practice, according to the president of the National Association of Primary Care.

  • Diabetes patients could be quizzed about driving habits during medication reviews

    30 OCT 2014

    People with diabetes could be questioned about their driving habits as part of their medication review, under proposals contained in a report by the Transport Research Laboratory.

  • Stronger warning on Iclusig blood clot risk

    30 OCT 2014

    Warnings about the risks of developing a blood clot or blocked artery with Iclusig (ponatinib), a leukaemia treatment, are to be made more robust, following the results of a European Medicines Agency review.

View results  10 per page   20 per page   50 per page  

Filter Your Search